Veeva Systems (NYSE:VEEV) will acquire Crossix Solutions in a deal that’s expected to close in November.
Veeva will pay $430M in cash plus provide certain Crossix employees with long-term equity retention grants valued at $120M.
The patient data and analytics company will remain an independent unit under its current brand and CEO.
Over 200 pharmaceutical brands use Crossix to help maximize media and marketing efficiencies.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.